CoChat
Sign Up
Cited by 55

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Fine mapping and resequencing of the PARK16 locus in Parkinson’s disease

Pihlstrøm, Lasse, Rengmark, Aina, Bjørnarå, Kari Anne, Dizdar, Nil, Fardell, Camilla, Forsgren, Lars, Holmberg, Björn, Larsen, Jan Petter, Linder, Jan, Nissbrandt, Hans, Tysnes, Ole-Bjørn, Dietrichs, Espen, Toft, Mathias·2015·Journal of Human Genetics
DOI 10.1038/jhg.2015.34
Open this paper in CoChat — free account

Abstract

The PARK16 locus, spanning five genes on chromosome 1, was among the first genetic regions to show genome-wide association in Parkinson's disease (PD). Subsequent investigations have found variability in PARK16 top-hits and association patterns across populations, and the implicated genes and mechanisms are currently unclear. In the present study, we aimed to explore the contribution of PARK16 variability to PD risk in a Scandinavian population. We genotyped 17 single-nucleotide polymorphisms in a case-control sample set of 2570 individuals from Norway and Sweden to fine map the locus. Targeted resequencing of the full coding regions of SLC45A3, NUCKS1, RAB7L1, SLC41A1 and PM20D1 was performed in DNA pools from a subset of 387 patient samples. We find evidence for an association with PD for rs1775143 as well as a haplotype located around the 5' region of RAB7L1, implicating variants which are not in high linkage disequilibrium with the strongest signal from a recent large meta-analysis in Caucasians. We also provide suggestive support for epistasis between RAB7L1 and LRRK2 as previously hypothesized by others. Comparing our results with previous work, allelic heterogeneity at PARK16 appears likely, and further studies are warranted to disentangle the complex patterns of association and pinpoint the functionally relevant variants.

Overview

Integrity signals

Registry

Crossref · 10.1038/jhg.2015.34

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 26

  1. Satake, W., Nakabayashi, Y., Mizuta, I., Hirota, Y., Ito, C. & Kubo, M. et al. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat. Genet. 41, 1303–1307 (2009). · DOI
  2. Simon-Sanchez, J., Schulte, C., Bras, J. M., Sharma, M., Gibbs, J. R. & Berg, D. et al. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat. Genet. 41, 1308–1312 (2009). · DOI · Paper page
  3. Hamza, T. H., Zabetian, C. P., Tenesa, A., Laederach, A., Montimurro, J. & Yearout, D. et al. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nat. Genet. 42, 781–785 (2010). · DOI
  4. Edwards, T. L., Scott, W. K., Almonte, C., Burt, A., Powell, E. H. & Beecham, G. W. et al. Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Ann. Hum. Genet. 74, 97–109 (2010). · DOI
  5. Spencer, C. C., Plagnol, V., Strange, A., Gardner, M., Paisan-Ruiz, C. & Band, G. et al. Dissection of the genetics of Parkinson's disease identifies an additional association 5′ of SNCA and multiple associated haplotypes at 17q21. Hum. Mol. Genet. 20, 345–353 (2011). · DOI
  6. Saad, M., Lesage, S., Saint-Pierre, A., Corvol, J. C., Zelenika, D. & Lambert, J. C. et al. Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European population. Hum. Mol. Genet. 20, 615–627 (2011). · DOI
  7. Nalls, M. A., Plagnol, V., Hernandez, D. G., Sharma, M., Sheerin, U. M. & Saad, M. et al. Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet 377, 641–649 (2011). · DOI
  8. International Parkinson's Disease Genomics Consortium (IPDGC), Wellcome Truste Case Control Consortium 2 (WTCCC2) A two-stage meta-analysis identifies several new loci for Parkinson's disease. PLoS Genet. 7, e1002142 (2011). · DOI
  9. Pankratz, N., Beecham, G. W., DeStefano, A. L., Dawson, T. M., Doheny, K. F. & Factor, S. A. et al. Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2. Ann. Neurol. 71, 370–384 (2012). · DOI
  10. Lill, C. M., Roehr, J. T., McQueen, M. B., Kavvoura, F. K., Bagade, S. & Schjeide, B. M. et al. Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: the PDGene database. PLoS Genet. 8, e1002548 (2012). · DOI
  11. Mata, I. F., Yearout, D., Alvarez, V., Coto, E., de Mena, L. & Ribacoba, R. et al. Replication of MAPT and SNCA, but not PARK16-18, as susceptibility genes for Parkinson's disease. Mov. Disord. 26, 819–823 (2011). · DOI
  12. Tucci, A., Nalls, M. A., Houlden, H., Revesz, T., Singleton, A. B. & Wood, N. W. et al. Genetic variability at the PARK16 locus. Eur. J. Hum. Genet. 18, 1356–1359 (2010). · DOI · Paper page
  13. Yan, Y., Tian, J., Mo, X., Zhao, G., Yin, X. & Pu, J. et al. Genetic variants in the RAB7L1 and SLC41A1 genes of the PARK16 locus in Chinese Parkinson's disease patients. Int. J. Neurosci. 121, 632–636 (2011). · DOI
  14. Kolisek, M., Sponder, G., Mastrototaro, L., Smorodchenko, A., Launay, P. & Vormann, J. et al. Substitution p.A350V in Na(+)/Mg(2)(+) exchanger SLC41A1, potentially associated with Parkinson's disease, is a gain-of-function mutation. PLoS One 8, e71096 (2013). · DOI
  15. MacLeod, D. A., Rhinn, H., Kuwahara, T., Zolin, A., Di Paolo, G. & McCabe, B. D. et al. RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk. Neuron 77, 425–439 (2013). · DOI · Paper page
  16. Pihlstrom, L., Axelsson, G., Bjornara, K. A., Dizdar, N., Fardell, C. & Forsgren, L. et al. Supportive evidence for 11 loci from genome-wide association studies in Parkinson's disease. Neurobiol. Aging 34, 1708e1707-1713 (2013). · DOI
  17. Pihlstrom, L., Rengmark, A., Bjornara, K. A. & Toft, M. Effective variant detection by targeted deep sequencing of DNA pools: an example from Parkinson's disease. Ann. Hum. Genet. 78, 243–252 (2014). · DOI
  18. Tan, E. K., Kwok, H. H., Tan, L. C., Zhao, W. T., Prakash, K. M. & Au, W. L. et al. Analysis of GWAS-linked loci in Parkinson disease reaffirms PARK16 as a susceptibility locus. Neurology 75, 508–512 (2010). · DOI
  19. Vilarino-Guell, C., Ross, O. A., Aasly, J. O., White, L. R., Rajput, A. & Rajput, A. H. et al. An independent replication of PARK16 in Asian samples. Neurology 75, 2248–2249 (2010). · DOI
  20. Ramirez, A., Ziegler, A., Winkler, S., Kottwitz, J., Giesen, R. & Diaz-Grez, F. et al. Association of Parkinson disease to PARK16 in a Chilean sample. Parkinsonism Relat. Disord. 17, 70–71 (2011). · DOI
  21. Chang, X. L., Mao, X. Y., Li, H. H., Zhang, J. H., Li, N. N. & Burgunder, J. M. et al. Association of GWAS loci with PD in China. Am. J. Med. Genet. B Neuropsychiatr. Genet. 156B, 334–339 (2011). · DOI
  22. Yan, Y. P., Mo, X. Y., Tian, J., Zhao, G. H., Yin, X. Z. & Jin, F. Y. et al. An association between the PARK16 locus and Parkinson's disease in a cohort from eastern China. Parkinsonism Relat. Disord. 17, 737–739 (2011). · DOI
  23. Wang, C., Cai, Y., Zheng, Z., Tang, B. S., Xu, Y. & Wang, T. et al. Penetrance of LRRK2 G2385R and R1628P is modified by common PD-associated genetic variants. Parkinsonism Relat. Disord. 18, 958–963 (2012). · DOI
  24. Zhou, L. L., Zhang, X., Bao, Q. Q., Liu, R. P., Gong, M. Y. & Mao, G. Y. et al. Association analysis of PARK16-18 variants and Parkinson's disease in a Chinese population. J. Clin. Neurosci. 21, 1029–1032 (2014). · DOI
  25. Soto-Ortolaza, A. I., Heckman, M. G., Labbe, C., Serie, D. J., Puschmann, A. & Rayaprolu, S. et al. GWAS risk factors in Parkinson's disease: LRRK2 coding variation and genetic interaction with PARK16. Am. J. Neurodegener. Dis. 2, 287–299 (2013).
  26. Gan-Or, Z., Bar-Shira, A., Dahary, D., Mirelman, A., Kedmi, M. & Gurevich, T. et al. Association of sequence alterations in the putative promoter of RAB7L1 with a reduced parkinson disease risk. Arch. Neurol. 69, 105–110 (2012). · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Pihlstrøm, L., Rengmark, A., Bjørnarå, K. A., Dizdar, N., Fardell, C., Forsgren, L., Holmberg, B., Larsen, J. P., Linder, J., Nissbrandt, H., Tysnes, O.-B., Dietrichs, E., & Toft, M.
Venue
Journal of Human Genetics
Publisher
Springer Science and Business Media LLC
Published
2015-04-09
Volume
60
Issue
7
Pages
357-362
ISSN
  • 1434-5161
  • 1435-232X
DOI
10.1038/jhg.2015.34
Cited by
55
References
4
Language
en
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review